Furthermore, mutated PTCH1 was proposed as a strong predictor of recurrence in breast cancer (58), and fusion of PTCH1 with glioma-associated proteins was associated with oncogenic activation in different tumors (59). This evidence concerns the gene PTCH1 and breast carcinoma.